Sample: Between 2013 and 2016, what percentage, overall, of US adults tried to lose weight in the past 12 months?
FDA Approves Second Generic OTC Naloxone Nasal Spray to Reverse Opioid Overdose
The newest generic OTC nonprescription naloxone hydrochloride nasal spray provides additional access to the lifesaving treatment, at potentially lower cost.
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight
Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
FDA Approves First New Antibiotic in Decades for Uncomplicated UTI
Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.
Food vs Medicine for IBS: Dietary Measures First, New Study Suggests
More participants consuming either of 2 common IBS dietary regimens experienced significant and sustained symptom relief vs those given pharmacotherapy.